Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

MJardin Group Inc MJARF

Healthcare Drug Manufacturers - Specialty & Generic Cannabis
MJardin Group is a cannabis management platform with extensive experience in cultivation, processing, distribution, and retail. For over 10 years, MJardin Group has refined cultivation methodologies, developed state of the art facilities, and implemented vertical integration for and on behalf of license owners. MJardin Group currently owns, manages or advises on a portfolio of 32 cannabis operations.


GREY:MJARF - Post by User

MJardin Group Inc
Bullboard Posts
User Avatar Image
(10)
•••
Comment by supra48on Jan 05, 2020 1:15pm
61 Views
Post# 30519821

RE:RE:news

RE:RE:news
crockdundy wrote: As long as the Cannacord/Cormac securities are behind MJAR there is nothing to fear. With this low trading volume of the day it looks like shorts are trying to cover. It is very good buy at this time at these low prices where O/S is very small. The stock started to  trade at 8.90 and now is at .25, and  see who is behind it. I bought in as much as I could in the open market and patiently waiting for the reversal to $5.00 which Cannacord and Cormac will make it happen. Happy trading.


Yes totally agree, if you look at their buy and sells in 2019 they have been net buyers.
Bullboard Posts
Dealroom for high-potential pre-IPO opportunities